The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer
Yip, D., Karapetis, C., Strickland, A., Steer, C. B., & Goldstein, D. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002093.pub2 · Cited by 160
RetractedJemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Estimates of the cancer incidence and mortality in Europe in 2006
Ferlay, J., Autier, P., Boniol, M., Heanue, M., Colombet, M., & Boyle, P. (2007) · Annals of Oncology · doi:10.1093/annonc/mdl498 · Cited by 4,036
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
RAS oncogenes: the first 30 years
Malumbres, M., & Barbacid, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1097 · Cited by 1,902 · cited 1×
“K-ras functions as a guanine nucleotide-binding protein involved in growth factor signal transduction [49].”
BackgroundMucins in cancer: protection and control of the cell surface
Hollingsworth, M. A., & Swanson, B. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1251 · Cited by 1,807
ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer
Locker, G. Y., Hamilton, S., Harris, J., Jessup, J. M., Kemeny, N., Macdonald, J. S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2644 · Cited by 1,592
Bloomston, M., Frankel, W. L., Petrocca, F., Volinia, S., Alder, H., Hagan, J. P., Liu, C.-G., Bhatt, D., Taccioli, C., & Croce, C. M. (2007) · JAMA · doi:10.1001/jama.297.17.1901 · Cited by 1,141
Expression profiling identifies microRNA signature in pancreatic cancer
Lee, E. J., Gusev, Y., Jiang, J., Nuovo, G. J., Lerner, M. R., Frankel, W. L., Morgan, D. L., Postier, R. G., Brackett, D. J., & Schmittgen, T. D. (2007) · International Journal of Cancer · doi:10.1002/ijc.22394 · Cited by 896
Goonetilleke, K. S., & Siriwardena, A. K. (2007) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2006.10.004 · Cited by 877
(1990) · PubMed · Cited by 579
Ferrone, C. R., Finkelstein, D. M., Thayer, S. P., Muzikansky, A., Castillo, C. F.-D., & Warshaw, A. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.3934 · Cited by 554
Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer
Sultana, A., Smith, C. T., Cunningham, D., Starling, N., Neoptolemos, J. P., & Ghaneh, P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2551 · Cited by 442
Biology and management of pancreatic cancer
Ghaneh, P., Costello, E., & Neoptolemos, J. P. (2008) · Postgraduate Medical Journal · doi:10.1136/gut.2006.103333 · Cited by 418
Berger, A. C., Garcia, M., Hoffman, J. P., Regine, W. F., Abrams, R. A., Safran, H., Konski, A., Benson, A. B., MacDonald, J., & Willett, C. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.6288 · Cited by 371
The role of microRNAs in cancer: No small matter
Wiemer, E. A. C. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.04.002 · Cited by 342
Carpelan-Holmström, M., Nordling, S., Pukkala, E., Sankila, R., Lüttges, J., Klöppel, G., & Haglund, C. (2005) · Gut · doi:10.1136/gut.2004.047191 · Cited by 313
Self-citationSerum Macrophage Inhibitory Cytokine 1 as a Marker of Pancreatic and Other Periampullary Cancers
Koopmann, J., Buckhaults, P., Brown, D. A., Zahurak, M. L., Sato, N., Fukushima, N., Sokoll, L. J., Chan, D. W., Yeo, C. J., Hruban, R. H., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0165 · Cited by 275
Molecular prognostic markers in pancreatic cancer: A systematic review
Garcea, G., Neal, C. P., Pattenden, C. J., Steward, W. P., & Berry, D. P. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.044 · Cited by 259
Hess, V., Glimelius, B., Grawe, P., Dietrich, D., Bodoky, G., Ruhstaller, T., Bajetta, E., Saletti, P., Figer, A., Scheithauer, W., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70001-9 · Cited by 239
CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.
Carpelan-Holmström, M. A., Louhimo, J. M., Stenman, U., Alfthan, H. V., & Haglund, C. (2002) · PubMed · Cited by 216
Self-citationMolecular markers of early pancreatic cancer
Goggins, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.19.711 · Cited by 214
Koopmann, J., Rosenzweig, C. N. W., Zhang, Z., Canto, M. I., Brown, D. A., Hunter, M., Yeo, C., Chan, D. W., Breit, S. N., & Goggins, M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0564 · Cited by 213
Halm, U., Schumann, T., Schiefke, I., Witzigmann, H., Mössner, J., & Keim, V (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1035 · Cited by 197
Pancreatic Adenocarcinoma Clinical Practice Guidelines in Oncology
(2005) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2005.0035 · Cited by 181
Role of tumor markers in patients with solid cancers: A critical review
Duffy, M. J. (2007) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2006.12.001 · Cited by 179
Self-citationRole of tumour markers, cytogenetics
Lamerz, R. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_4.s145 · Cited by 178
Self-citationBoeck, S., Stieber, P., Holdenrieder, S., Wilkowski, R., & Heinemann, V. (2006) · Oncology · doi:10.1159/000094888 · Cited by 172
Self-citationZiske, C., Schlie, C., Gorschlüter, M., Glasmacher, A., Mey, U., Strehl, J., Sauerbruch, T., & Schmidt-Wolf, I. G. H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601263 · Cited by 167
Sturgeon, C. M., Hoffman, B. R., Chan, D. W., Ch'ng, S.-L., Hammond, E., Hayes, D. F., Liotta, L. A., Petricoin, E. F., Schmitt, M., Semmes, O. J., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.094144 · Cited by 166
Self-citationKo, A. H., Hwang, J., Venook, A. P., Abbruzzese, J. L., Bergsland, E. K., & Tempero, M. A. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602687 · Cited by 165
Vestergaard, E. M., Hein, H. O., Meyer, H., Grunnet, N., Jørgensen, J. B., Wolf, H., & Orntoft, T. F. (1999) · PubMed · Cited by 164
Elevated serum levels of tumor marker CA19-9 in acute cholangitis
Albert, M. B., Steinberg, W. M., & Henry, J. P. (1988) · Digestive Diseases and Sciences · doi:10.1007/bf01536670 · Cited by 158
Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy
Moniaux, N., Andrianifahanana, M., Brand, R. E., & Batra, S. K. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602163 · Cited by 156
Chen, R., Brentnall, T. A., Pan, S., Cooke, K., Moyes, K. W., Lane, Z., Crispin, D. A., Goodlett, D. R., Aebersold, R. H., & Bronner, M. P. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700072-mcp200 · Cited by 156
Heinemann, V., Labianca, R., Hinke, A., & Louvet, C. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm283 · Cited by 138
Self-citationCA 19-9 as a Marker for Gastrointestinal Cancers: A Review
Duffy, M. J. (1998) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329803500304 · Cited by 126
Self-citationTumor-Node-Metastasis Staging of Pancreatic Adenocarcinoma
Katz, M. H. G., Hwang, R. F., Fleming, J. B., & Evans, D. B. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0012 · Cited by 113
Saad, E. D., Machado, M. C. C., Wajsbrot, D., Abramoff, R., Hoff, P. M., Tabacof, J., Katz, A., Simon, S. D., & Gansl, R. C. (2002) · International Journal of Gastrointestinal Cancer · doi:10.1385/ijgc:32:1:35 · Cited by 107
p53: link to the past, bridge to the future
Mills, A. A. (2005) · Genes & Development · doi:10.1101/gad.1362905 · Cited by 105
Jimeno, A., & Hidalgo, M. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0005 · Cited by 103
Metastatic Pancreatic Cancer 2008: Is the Glass Less Empty?
Nieto, J., Grossbard, M. L., & Kozuch, P. S. (2008) · The Oncologist · doi:10.1634/theoncologist.2007-0181 · Cited by 102
A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma
Rothenberg, M. L., Abbruzzese, J. L., Moore, M. J., Portenoy, R. K., Robertson, J. M., & Wanebo, H. J. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960801)78:3<627::aid-cncr43>3.0.co;2-y · Cited by 92
Gemcitabine‐based combinations for inoperable pancreatic cancer: Have we made real progress?
Bria, E., Milella, M., Gelibter, A. J., Cuppone, F., Pino, M. S., Ruggeri, E. M., Carlini, P., Nisticò, C., Terzoli, E., Cognetti, F., et al. (2007) · Cancer · doi:10.1002/cncr.22809 · Cited by 89
Däbritz, J., Hänfler, J., Preston, R., Stieler, J., & Oettle, H. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602319 · Cited by 87
Circulating Insulin-Like Growth Factor Binding Protein-1 and the Risk of Pancreatic Cancer
Wolpin, B. M., Michaud, D. S., Giovannucci, E. L., Schernhammer, E. S., Stampfer, M. J., Manson, J. E., Cochrane, B. B., Rohan, T. E., Ma, J., Pollak, M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0373 · Cited by 74
Takasaki, H., Uchida, E., Tempero, M. A., Burnett, D. A., Metzgar, R. S., & Pour, P. M. (1988) · PubMed · Cited by 68
Wolpin, B. M., Michaud, D. S., Giovannucci, E. L., Schernhammer, E. S., Stampfer, M. J., Manson, J. E., Cochrane, B. B., Rohan, T. E., Ma, J., Pollak, M., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603826 · Cited by 64
Performance Characteristics of Five Automated CA 19-9 Assays
La’ulu, S. L., & Roberts, W. L. (2007) · American Journal of Clinical Pathology · doi:10.1309/h52vet3m6p7gywg1 · Cited by 63
Wang, Y., Gao, J., Li, Z., Jin, Z., Gong, Y.-F., & Man, X. (2007) · International Journal of Cancer · doi:10.1002/ijc.22997 · Cited by 61
Tumour markers in prostate cancer: EGTM recommendations
Semjonow, A., Albrecht, W., Bialk, P., Gerl, A., Lamerz, R., Hp, S., & Poppel, H. V. (1999) · Anticancer Research · Cited by 57
Self-citationFirpo, M. A., Gay, D. Z., Granger, S. R., Scaife, C. L., DiSario, J. A., Boucher, K. M., & Mulvihill, S. J. (2008) · World Journal of Surgery · doi:10.1007/s00268-008-9853-9 · Cited by 53
New carbohydrate tumor markers
Itzkowitz, S. H., & Kim, Y. S. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90954-6 · Cited by 53
Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications.
Talar‐Wojnarowska, R., & Malecka-Panas, E. I. (2006) · PubMed · Cited by 52
Berndt, C., Haubold, K., Wenger, F. A., Brux, B., Müller, J., Bendzkô, P., Hillebrand, T., Köttgen, E., & Zanow, J. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.10.2103 · Cited by 48
Tumor M2-Pyruvate Kinase as Tumor Marker in Exocrine Pancreatic Cancer A Meta-Analysis
Kumar, Y., Gurusamy, K. S., Pamecha, V., & Davidson, B. R. (2007) · Pancreas · doi:10.1097/mpa.0b013e3180537237 · Cited by 38
Comparison of three immunoassays for CA 19-9
Hotakainen, K., Tanner, P., Alfthan, H. V., Haglund, C. H., & Stenman, U. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.10.033 · Cited by 38
Self-citationPlebani, M., Giacomini, A., Beghi, L., Paoli, M. D., Roveroni, G., Galeotti, F., Corsini, A., & Fraser, C. G. (1996) · PubMed · Cited by 27
Móra, J., Urgell, E., Farré, A., Comas, L., Montserrat, E., & González‐Sastre, F. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.067140 · Cited by 19
Adjuvant Therapy for Pancreatic Cancer
Benson, A. B. (2007) · JAMA · doi:10.1001/jama.297.3.311 · Cited by 17
Teich, N., & Mössner, J. (2004) · Digestive Diseases · doi:10.1159/000082794 · Cited by 15
Microarray Technologies for Gene Transcript Analysis in Pancreatic Cancer
Kolbert, C. P., Chari, S. T., & Sreekumar, R. (2008) · Technology in Cancer Research & Treatment · doi:10.1177/153303460800700107 · Cited by 7
Cited by
Ballehaninna, U. K., & Chamberlain, R. S. (2012) · PubMed · doi:10.3978/j.issn.2078-6891.2011.021 · Cited by 701
Extracellular vesicles as biomarkers and therapeutic targets for cancer
Urabe, F., Kosaka, N., Ito, K., Kimura, T., Egawa, S., & Ochiya, T. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00280.2019 · Cited by 397
Pancreatic Cancer: Yesterday, Today and Tomorrow
Ansari, D., Tingstedt, B., Andersson, B., Holmquist, F., Sturesson, C., Williamsson, C., Sasor, A., Borg, D., Bauden, M., & Andersson, R. (2016) · Future Oncology · doi:10.2217/fon-2016-0010 · Cited by 385
Khorana, A. A., Mangu, P. B., Berlin, J., Engebretson, A., Hong, T. S., Maitra, A., Mohile, S. G., Mumber, M., Schulick, R., Shapiro, M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.5553 · Cited by 366
CA 19-9: Biochemical and Clinical Aspects
Scarà, S., Bottoni, P., & Scatena, R. (2015) · Advances in Experimental Medicine and Biology · doi:10.1007/978-94-017-7215-0_15 · Cited by 351
Metadata
- Authors
- Duffy, M. J., Sturgeon, C., Lamerz, R., Haglund, C., Holubec, V. L., Klapdor, R., Nicolini, A., Topolcan, O., & Heinemann, V.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 21
- Issue
- 3
- Pages
- 441-447
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2102803053
- Cited by
- 381
- References
- 64
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.